Histamine and histamine intolerance

American Journal of Clinical Nutrition

Volumn 85, Issue 5, 2007, Pages 1185-1196

  Maintz, Laura ^a   Novak, Natalija ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Allergy; Diamine oxidase; Food intolerance; Histamine; Histamine intolerance

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING); ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BRONCHODILATING AGENT; CIMETIDINE; CONTRAST MEDIUM; CYTOSTATIC AGENT; DIHYDRALAZINE; DIPHENHYDRAMINE; DIURETIC AGENT; ESTROGEN; GASTROINTESTINAL AGENT; HISTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE METHYLTRANSFERASE; HYPERTENSIVE AGENT; LOCAL ANESTHETIC AGENT; MUCOLYTIC AGENT; MUSCLE RELAXANT AGENT; NARCOTIC AGENT; PLACEBO; SULFITE; TYRAMINE;

ALLERGIC REACTION; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; FOOD ALLERGY; GASTROINTESTINAL SYMPTOM; HISTAMINE METABOLISM; HISTAMINE RELEASE; HUMAN; MIGRAINE; PREVALENCE; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPORAL ARTERITIS;

EID: 34248324818     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.5.1185     Document Type: Article

References (137)

1. Silla Santos MH. Biogenic amines: their importance in foods. Int J Food Microbiol 1996;29:213-31.
2. Bieganski T, Kusche J, Feussner KD, Hesterberg R, Richter H, Lorenz W. Human intestinal diamine oxidase: substrate specificity and comparative inhibitor study. Agents Actions 1980;10:108-10.
3. Bieganski T, Kusche J, Feussner KD, Hesterberg R, Richter H, Lorenz W. The importance of human intestinal diamine oxidase in the oxidation of histamine and/or putrescine. Arch Immunol Ther Exp (Warsz) 1980;28:901-6.
4. Bieganski T, Kusche J, Lorenz W, Hesterberg R, Stahlknecht CD, Feussner KD. Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolism. Biochim Biophys Acta 1983;756:196-203.
5. Bieganski T. Biochemical, physiological and pathophysiological aspects of intestinal diamine oxidase. Acta Physiol Pol 1983;34:139-54.
6. Sattler J, Hafner D, Klotter HJ, Lorenz W, Wagner PK. Food-induced histaminosis as an epidemiological problem: plasma histamine elevation and haemodynamic alterations after oral histamine administration and blockade of diamine oxidase (DAO). Agents Actions 1988;23:361-5.
7. Wantke F, Gotz M, Jarisch R. The red wine provocation test: intolerance to histamine as a model for food intolerance. Allergy Proc 1994;15:27-32.
8. Wantke F, Hemmer W, Haglmuller T, Gotz M, Jarisch R. Histamine in wine. Bronchoconstriction after a double-blind placebo-controlled red wine provocation test. Int Arch Allergy Immunol 1996;110:397-400.
9. Zimatkin SM, Anichtchik OV. Alcohol-histamine interactions. Alcohol Alcohol 1999;34:141-7.
10. Sattler J, Lorenz W. Intestinal diamine oxidases and enteral-induced histaminosis: studies on three prognostic variables in an epidemiological model. J Neural Transm Suppl 1990;32:291-314.
11. Wantke F, Hemmer W, Focke M, Stackl W, Gotz M, Jarisch R. Are adverse effects of sildenafil also caused by inhibition of diamine oxidase? Urol Int 2001;67:59-61.
12. Sattler J, Hesterberg R, Schmidt U, Crombach M, Lorenz W. Inhibition of intestinal diamine oxidase by detergents: a problem for drug formulations with water insoluble agents applied by the intravenous route? Agents Actions 1987;20:270-3.
13. Jarisch R, ed. Histamin-Intoleranz. Histamin und Seekrankheit. (Histamine intolerance. Histamine and motion sickness.) Stuttgart, Germany: Georg Thieme Verlag KG, 2004 (in German).
14. Jarisch R, Wantke F. Wine and headache. Int Arch Allergy Immunol 1996;110:7-12.
15. Wohrl S, Hemmer W, Focke M, Rappersberger K, Jarisch R. Histamine intolerance-like symptoms in healthy volunteers after oral provocation with liquid histamine. Allergy Asthma Proc 2004;25:305-11.
16. Pollock I, Murdoch RD, Lessof MH. Plasma histamine and clinical tolerance to infused histamine in normal, atopic and urticarial subjects. Agents Actions 1991;32:359-65.
17. Schmidt WU, Sattler J, Hesterberg R, et al. Human intestinal diamine oxidase (DAO) activity in Crohn's disease: a new marker for disease assessment? Agents Actions 1990;30:267-70.
18. Missbichler A. Diagnostischer Nachweis der Aktivität von Diaminooxidase in Serum oder Plasma. (Diagnostic proof of the DAO activity in serum and plasma.) In: Jarisch R, ed. Histamin-Intoleranz. Histamin und Seekrankheit. (Histamine intolerance. Histamine and motion sickness.) Stuttgart, Germany: Georg Thieme Verlag KG, 2004:8-17 (in German).
19. Jansen SC, van DM, Bottema KC, Dubois AE. Intolerance to dietary biogenic amines: a review. Ann Allergy Asthma Immunol 2003;91:233-40.
20. Dale HD, Laidlaw PD. The physiological action of β-iminazolyl- ethylamine. J Physiol (Lond) 1910;41:318-44.
21. Steinhoff M, Griffiths C, Church M, Lugar TA. Histamine. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook's textbook of dermatology. Oxford, United Kingdom: Blackwell Science, 2004:9.50-2.
22. Vlieg-Boerstra BJ, van der HS, Oude Elberink JN, Kluin-Nelemans JC, Dubois AE. Mastocytosis and adverse reactions to biogenic amines and histamine-releasing foods: what is the evidence? Neth J Med 2005;63:244-9.
23. Ring J. Angewandte Allergologie. (Implemented allergology.) Munich, Germany: Urban & Vogel, 2004 (in German).
24. Raithel M, Ulrich P, Hochberger J, Hahn EG. Measurement of gut diamine oxidase activity. Diamine oxidase as a new biologic marker of colorectal proliferation? Ann N Y Acad Sci 1998;859:262-6.
25. Kusche J, Bieganski T, Hesterberg R, et al. The influence of carcinoma growth on diamine oxidase activity in human gastrointestinal tract. Agents Actions 1980;10:110-3.
26. Kalchmair B, Klocker J, Perkmann R, et al. Alterations in plasma amine oxidase activities in a compartment syndrome model. Inflamm Res 2003;52(suppl)1:S67-8.
27. Schwelberger HG. Diamine oxidase(DAO)enzyme and gene. In: Falus A, ed. Histamine: biology and medical aspects. Budapest, Hungary: SpringMed Publishing, 2004:43-52.
28. Schwelberger HG, Hittmair A, Kohlwein SD. Analysis of tissue and subcellular localization of mammalian diamine oxidase by confocal laser scanning fluorescence microscopy. Inflamm Res 1998;47(suppl):S60-1.
29. Schwelberger HG, Bodner E. Purification and characterization of diamine oxidase from porcine kidney and intestine. Biochim Biophys Acta 1997;1340:152-64.
30. Brown DD, Tomchick R, Axelrod J. The distribution and properties of a histamine-methylating enzyme. J Biol Chem 1959;234:2948-50.
31. Klocker J, Matzler SA, Huetz GN, Drasche A, Kolbitsch C, Schwelberger HG. Expression of histamine degrading enzymes in porcine tissues. Inflamm Res 2005;54(suppl):S54-7.
32. Kufner MA, Ulrich P, Raithel M, Schwelberger HG. Determination of histamine degradation capacity in extremely small human colon samples. Inflamm Res 2001;50(suppl):S96-7.
33. Raithel M, Kufner M, Ulrich P, Hahn EG. The involvement of the histamine degradation pathway by diamine oxidase in manifest gastrointestinal allergies. Inflamm Res 1999;48(suppl):S75-6.
34. Backhaus B, Raithel M, Hahn EG. Nicht-immunologisch induzierte Histaminfreisetzung an vitalen menschlichen Darmschleimhautbiopsien durch Stimulation mit Polyaminen. (Nonimmunologically induced histamine release of biopsies of vital human intestinal mucosa after stimulation with polyamines.) Allergo J 2005;14:41 (abstr) (in German).
35. Tsujikawa T, Uda K, Ihara T, Andoh A, Fujiyama Y, Bamba T. Changes in serum diamine oxidase activity during chemotherapy in patients with hematological malignancies. Cancer Lett 1999;147:195-8.
36. Schwelberger HG. Histamine N-methyltransferase (HNMT) enzyme and gene. In: Falus A, ed. Histamine: biology and medical aspects. Budapest, Hungary: SpringMed Publishing, 2004:53-9.
37. Yamauchi K, Sekizawa K, Suzuki H, et al. Structure and function of human histamine N-methyltransferase: critical enzyme in histamine metabolism in airway. Am J Physiol 1994;267:L342-9.
38. Raithel M. Durchfälle und weicher Stuhl. In: Jarisch R, ed. Histamin-Intoleranz. Histamin und Seekrankheit. (Histamine intolerance. Histamine and motion sickness.) Stuttgart, Germany: Georg Thieme Verlag KG, 2004:77-110 (in German).
39. Raithel M, Matek M, Baenkler HW, Jorde W, Hahn EG. Mucosal histamine content and histamine secretion in Crohn's disease, ulcerative colitis and allergic enteropathy. Int Arch Allergy Immunol 1995;108:127-33.
40. Sattler J, Hesterberg R, Lorenz W, Schmidt U, Crombach M, Stahlknecht CD. Inhibition of human and canine diamine oxidase by drugs used in an intensive care unit: relevance for clinical side effects? Agents Actions 1985;16:91-4.
41. Ahrens F, Gabel G, Garz B, Aschenbach JR. Release and permeation of histamine are affected by diamine oxidase in the pig large intestine. Inflamm Res 2002;51(suppl):S83-4.
42. Aschenbach JR, Oswald R, Gäbel G. Gastrointestinal epithelia as barriers to luminal histamine of microbial origin. Z Gastroenterol 1998;36:12-7.
43. Sattler J, Lorenz W, Kubo K, Schmal A, Sauer S, Luben L. Food-induced histaminosis under diamine oxidase (DAO) blockade in pigs: further evidence of the key role of elevated plasma histamine levels as demonstrated by successful prophylaxis with antihistamines. Agents Actions 1989;27:212-4.
44. Petersen J, Raithel M, Schwelberger HG. Characterisation of functional polymorphisms of the human diamine oxidase gene. Inflamm Res 2005;54(suppl):S58-9.
45. Petersen J, Drasche A, Raithel M, Schwelberger HG. Analysis of genetic polymorphisms of enzymes involved in histamine metabolism. Inflamm Res 2003;52(suppl):S69-70.
46. Schwelberger HG, Drasche A, Petersen J, Raithel M. Genetic polymorphisms of histamine degrading enzymes: from small-scale screening to high-throughput routine testing. Inflamm Res 2003;52(suppl):S71-3.
47. Petersen J, Raithel M, Schwelberger HG. Histamine N- methyltransferase and diamine oxidase gene polymorphisms in patients with inflammatory and neoplastic intestinal diseases. Inflamm Res 2002;51(suppl):S91-2.
48. Yan L, Galinsky RE, Bernstein JA, Liggett SB, Weinshilboum RM. Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma. Pharmacogenetics 2000;10:261-6.
49. Sasaki Y, Ihara K, Ahmed S, et al. Lack of association between atopic asthma and polymorphisms of the histamine H1 receptor, histamine H2 receptor, and histamine N-methyltransferase genes. Immunogenetics 2005;51:238-40.
50. Deindl P, Peri-Jerkan S, Deichmann K, et al. No association of histamine-N-methyltransferase polymorphism with asthma or bronchial hyperresponsiveness in two German pediatric populations. Pediatr Allergy Immunol 2005;16:40-2.
51. Sharma S, Mann D, Singh TP, Ghosh B. Lack of association of histamine-N-methyltransferase (HNMT) polymorphisms with asthma in the Indian population. J Hum Genet 2005;50:611-7.
52. Dyer J, Warren K, Merlin S, Metcalfe DD, Kaliner M. Measurement of plasma histamine: description of an improved method and normal values. J Allergy Clin Immunol 1982;70:82-7.
53. Kaliner M, Shelhamer JH, Ottesen EA. Effects of infused histamine: correlation of plasma histamine levels and symptoms. J Allergy Clin Immunol 1982;69:283-9.
54. Ind PW, Brown MJ, Lhoste FJ, Macquin I, Dollery CT. Concentration effect relationships of infused histamine in normal volunteers. Agents Actions 1982;12:12-6.
55. Morrow JD, Margolies GR, Rowland J, Roberts LJ. Evidence that histamine is the causative toxin of scombroid-fish poisoning. N Engl J Med 1991;324:716-20.
56. Hershko AY, Dranitzki Z, Ulmanski R, Levi-Schaffer F, Naparstek Y. Constitutive hyperhistaminaemia: a possible mechanism for recurrent anaphylaxis. Scand J Clin Lab Invest 2001;61:449-52.
57. Steinbrecher I, Jarisch R. Histamin und Kopfschmerz. (Histamine and headache. ) Allergologie 2005;28:84-91 (in German).
58. Curtis MJ, Pugsley MK, Walker MJ. Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease. Cardiovasc Res 1993;27:703-19.
59. Endou M, Levi R. Histamine in the heart. Eur J Clin Invest 1995;25(suppl):5-11.
60. Lessof MH, Gant V, Hinuma K, Murphy GM, Dowling RH. Recurrent urticaria and reduced diamine oxidase activity. Clin Exp Allergy 1990;20:373-6.
61. Lassen LH, Heinig JH, Oestergaard S, Olesen J. Histamine inhalation is a specific but insensitive laboratory test for migraine. Cephalalgia 1996;16:550-3.
62. Thomsen LL, Olesen J. Nitric oxide in primary headaches. Curr Opin Neurol 2001;14:315-21.
63. Thomsen LL. Investigations into the role of nitrc oxide and the large intracanial arteries in migraine headache. Cephalalgia 1997;17:873-95.
64. Huszti Z. Histamine in CNS-resident non-neuronal cells. In: Falus A, Grosman N, Darvas Z, eds. Histamine: biology and medical aspects. Budapest, Hungary: SpringMed Publishing, 2004:272-80.
65. Wantke F, Gotz M, Jarisch R. Histamine-free diet: treatment of choice for histamine-induced food intolerance and supporting treatment for chronic headaches. Clin Exp Allergy 1993;23:982-5.
66. Krabbe AA, Olesen J. Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanisms. Pain 1980;8:253-9.
67. Mennigen R, Kusche J, Streffer C, Krakamp B. Diamine oxidase activities in the large bowel mucosa of ulcerative colitis patients. Agents Actions 1990;30:264-6.
68. Raithel M, Ulrich P, Keymling J, Hahn EG. Analysis and topographical distribution of gut diamine oxidase activity in patients with food allergy. Ann N Y Acad Sci 1998;859:258-61.
69. Kuefner MA, Schwelberger HG, Ulrich P, Hahn EG, Raithel M. Total histamine degradation capacity (THDC) as an important biological marker of histamine metabolism in human colonic mucosa. Inflamm Res 2002;51(suppl):S87-8.
70. Kuefner MA, Schwelberger HG, Weidenhiller M, Hahn EG, Raithel M. Both catabolic pathways of histamine via histamine-N-methyltransferase and diamine oxidase are diminished in the colonic mucosa of patients with food allergy. Inflamm Res 2004;53(suppl):S31-2.
71. Preuss CV, Wood TC, Szumlanski CL, et al. Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol Pharmacol 1998;53:708-17.
72. Bodmer S, Imark C, Kneubuhl M. Biogenic amines in foods: histamine and food processing. Inflamm Res 1999;48:296-300.
73. Sarkadi L. Histamine in food. In: Falus A, Grosman N, Darvas Z, eds. Histamine: biology and medical aspects. Budapest, Hungary: SpringMed Publishing, 2004:176-85.
74. Bover-Cid S, Holzapfel W. Biogenic amine production by bacteria. In: Morgan D, White A, Sánchez-Jiménez F, Bardócz S, eds. Biogenically active amines in food. Luxembourg City, Luxembourg: EC Publication, 2000:20-9.
75. Beutling DM. Biogene Amine in der Ernährung. (Biogenic amines in nutrition.) Berlin, Germany: Springer, 1996 (in German).
76. Pechanek U, Pfannhauser W, Woidich H. [Content of biogenic amines in four food groups of the Austrian marketplace]. Z Lebensm Unters Forsch 1983;176:335-40 (in German).
77. Halász A, Baráth, Á, Simon-Sarkadi L, Holzapfel WH. Biogenic amines and their production by microorganisms in food. Trends Food Sci Technol 1994;5:42-9.
78. Nordic Council of Ministers. Present status of biogenic amines in foods in Nordic countries. Tema Nord 2002:524 (ISBN: 92-893-0773-0). Cited by: Sarkadi L. Histamine in food. In: Falus A, Grosman N, Darvas Z, eds. Histamine: biology and medical aspects. Budapest, Hungary: SpringMed Publishing, 2004:176-85.
79. Bieck PR, Antonin KH. Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: comparison of brofaromine and tranylcypromine in healthy subjects. J Clin Psychopharmacol 1988;8:237-45.
80. Littlewood JT, Gibb C, Glover V, Sandler M, Davies PT, Rose FC. Red wine as a cause of migraine. Lancet 1988;1:558-9.
81. Forsythe WI, Redmond A. Two controlled trials of tyramine in children with migraine. Dev Med Child Neurol 1974;16:794-9.
82. Ziegler DK, Stewart R. Failure of tyramine to induce migraine. Neurology 1977;27:725-6.
83. Moffett A, Swash M, Scott DF. Effect of tyramine in migraine: a double-blind study. J Neurol Neurosurg Psychiatry 1972;35:496-9.
84. Ryan RE. A clinical study of tyramine as an etiological factor in migraine. Headache 1974;14:43-8.
85. Moneret-Vautrin DA, de Korwin JD, Tisserant J, Grignon M, Claudot N. Ultrastructural study of the mast cells of the human duodenal mucosa. Clin Allergy 1984;14:471-81.
86. Izquierdo-Pulido, M. Biogenic amines in European beers. J Agric Food Chem 1996;44:33159-63.
87. Jarisch R, Pirker C, Möslinger T, Götz M. The role of histamine in wine intolerance. J Allergy Clin Immunol 1992;91:197 (abstr).
88. Wantke F, Hemmer W, Gotz M, Jarisch R. Adverse reactions to alcoholic beverages: a diagnostic guideline. Clin Exp Allergy 1997;27:343 (abstr).
89. Dahl R, Henriksen JM, Harving H. Red wine asthma: a controlled challenge study. J Allergy Clin Immunol 1986;78:1126-9.
90. Gershwin ME, Ough C, Bock A, Fletcher MP, Nagy SM, Tuft DS. Grand rounds: adverse reactions to wine. J Allergy Clin Immunol 1985;75:411-20.
91. Kanny G, Bauza T, Fremont S, et al. Histamine content does not influence the tolerance of wine in normal subjects. Allerg Immunol (Paris) 1999;31:45-8.
92. Kanny G, Gerbaux V, Olszewski A, et al. No correlation between wine intolerance and histamine content of wine. J Allergy Clin Immunol 2001;107:375-8.
93. Yang WH, Purchase EC. Adverse reactions to sulfites. CMAJ 1985;133:865-7, 880.
94. Gunnison AF, Jacobsen DW. Sulfite hypersensitivity. A critical review. CRC Crit Rev Toxicol 1987;17:185-214.
95. Przybilla B, Ring J. [Sulfite hypersensitivity]. Hautarzt 1987;38:445-8 (in German).
96. Brink B, Damink C., Joosten HM, Huis in 't Veld JH. Occurrence and formation of biologically active amines in foods Int J Food Microbiol 1990;11:73-84.
97. Wantke F, Proud D, Siekierski E, Kagey-Sobotka A. Daily variations of serum diamine oxidase and the influence of H1 and H2 blockers: a critical approach to routine diamine oxidase assessment. Inflamm Res 1998;47:396-400.
98. Novotny WF, Chassande O, Baker M, Lazdunski M, Barbry P. Diamine oxidase is the amiloride-binding protein and is inhibited by amiloride analogues. J Biol Chem 1994;269:9921-5.
99. Stein J, Scheuermann EH, Yazdi R, Lembcke B, Caspary WF. Reduced postheparin plasma diamine oxidase activity in patients with chronic renal failure. Z Gastroenterol 1994;32:236-9.
100. Gang V, Berneburg H, Hennemann H, Hevendehl G. Diamine oxidase (histaminase) in chronic renal disease and its inhibition in vitro by methylguanidine. Clin Nephrol 1976;3:171-7.
101. Gang V, Stanjek J, Gaubitz W. [Diaminooxidase (histaminase) in liver diseases and experimental liver lesions]. Verh Dtsch Ges Inn Med 1976;82:434-6 (in German).
102. Ruan P, Gong ZJ, Zhang QR. Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int 2004;3:58-61.
103. Guida B, De Martino CD, De Martino SD, et al. Histamine plasma levels and elimination diet in chronic idiopathic urticaria. Eur J Clin Nutr 2000;54:155-8.
104. Ionescu G, Kiehl, R. Monoamine and diamine oxidase activities in atopic eczema. Allergy 1988;43:318-9.
105. Ring, J. Plasma histamine concentrations in atopic eczema. Clin Allergy 1983;13:545-52.
106. Ring J, Sedlmeier F, Dorsch W, Hermann K. In vitro IgE eluation and histamine releasability from peripheral leukocytes of atopics and normals. J Dermatol Sci 1991;2:413-21.
107. Ring J, O'Connor R. In vitro histamine and serotonin release studies in atopic dermatitis. Int Arch Allergy Appl Immunol 1979;58:322-30.
108. Ring J, Thomas P. Histamine and atopic eczema. Acta Derm Venereol Suppl (Stockh) 1989;144:70-7.
109. Sampson HA, Jolie P. L. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis. N Engl J Med 1984;311:372-6.
110. Kiehl R, Ionescu G. [Histamine-degrading enzymes in atopic eczema]. Z Hautkr 1989;64:1121-3 (in German).
111. Maintz L, Benfadal S, Allam JP, Hagemann T, Fimmers R, Novak N. Evidence for a reduced histamine degradation capacity in a subgroup of patients with atopic eczema. J Allergy Clin Immunol 2006;117:1106-12.
112. Fiedler EM, Pelchrzim R, Focke M, Zuberbier T, Worm M. Bedeutungvon exogen zugeführtem Histamin bei Patienten mit atopischer Dermatitis. (Histamine intolerance. Effect of ingested histamine on the skin status of atopic patients.) Allergo J 2004;13:S49-50 (abstr) (in German).
113. Bieganski T, Osinska Z, Maslinski C. Inhibition of plant and mammalian diamine oxidase by substrate analogues. Agents Actions 1982;12:41-6.
114. Herman JJ, Brenner JK, Colten HR. Inhibition of histaminase release from human granulocytes by products of histaminase activity. Science 1979;206:77-8.
115. Elmore BO, Bollinger JA, Dooley DM. Human kidney diamine oxidase: heterologous expression, purification, and characterization. J Biol Inorg Chem 2002;7:565-79.
116. Ignesti G. Equations of substrate-inhibition kinetics applied to pig kidney diamine oxidase (DAO, E.C. 1.4.3.6). J Enzyme Inhib Med Chem 2003;18:463-73.
117. Bodis J, Tinneberg HR, Schwarz H, Papenfuss F, Torok A, Hanf V. The effect of histamine on progesterone and estradiol secretion of human granulosa cells in serum-free culture. Gynecol Endocrinol 1993;7:235-9.
118. Kalogeromitros D, Katsarou A, Armenaka M, Rigopoulos D, Zapanti M, Stratigos I. Influence of the menstrual cycle on skin-prick test reactions to histamine, morphine and allergen. Clin Exp Allergy 1995;25:461-6.
119. Sabbah A, Heulin MG, Drouet M, Bonneau JC, Sellin JL, Bouquin D. [Antihistaminic or antidegranulating activity of pregnancy serum]. Allerg Immunol (Paris) 1988;20:236-40 (in French).
120. Morel F, Surla A, Vignais PV. Purification of human placenta diamine oxidase. Biochem Biophys Res Commun 1992;187:178-86.
121. Lindberg S. 14-C-histamine elimination from the blood of pregnant and non-pregnant women with special reference to the uterus. Acta Obstet Gynecol Scand 1963;42(suppl):3-25.
122. Jarisch R. Histamin-Intoleranz. (Histamine intolerance. ) Aerztemagazin 2004;8:1-4 (in German).
123. Tufvesson G, Tryding N. Determination of diamine oxidase activity in normal human blood serum. Scand J Clin Lab Invest 1969;24:163-8.
124. Okuyama T, Kobayashi Y. Determination of diamine oxidase activity by liquid scintillation counting. Arch Biochem Biophys 1961;95:242-50.
125. Schwelberger HG, Klocker J, Sattler J, Bodner E. Determination of the activity of diamine oxidase in extremely small tissue samples. Inflamm Res 1995;44(suppl):S94-5.
126. Pacifici GM, Donatelli P, Giuliani L. Histamine N-methyl transferase: inhibition by drugs. Br J Clin Pharmacol 1992;34:322-7.
127. Hansson R, Holmberg CG, Tibbling G, Tryding N, Westling H, Wetterqvist H. Heparin-induced diamine oxidase increase in human blood plasma. Acta Med Scand 1966;180:533-6.
128. Klocker J, Perkmann R, Klein-Weigel P, et al. Continuous administration of heparin in patients with deep vein thrombosis can increase plasma levels of diamine oxidase. Vascul Pharmacol 2004;40:293-300.
129. Biebl M, Klocker J, Perkmann R, et al. Effects of unfractionated and low molecular weight heparins on diamine oxidase release. Inflamm Res 2003;52(suppl):S63-4.
130. Biebl M, Klocker J, Perkmann R, et al. Heparin-induced diamine oxidase release into the circulation in pigs. Inflamm Res 2002;51(suppl):S93-4.
131. Mayer I, Missbichler A, Wantke F, et al. Optimierter Radioextraktionsassay zur quantitativen Bestimmung der Aktivität von Diaminooxidase (DAO) in humanem Serum und Plasma. (Optimized radio-extraction assay for the quantitative measurement of the activity of diamine oxidase (DAO) in human serum and plasma. ) Allergologie 2005;28:1-8 (in German).
132. Hermann K, Hertenberger B, Ring J. Measurement and characterization of histamine and methylhistamine in human urine under histamine-rich and histamine-poor diets. Int Arch Allergy Immunol 1993;101:13-9.
133. Johnston CS. The antihistamine action of ascorbic acid. Subcell Biochem 1996;25:189-213.
134. Wantke F, Gotz M, Jarisch R. [The histamine-free diet]. Hautarzt 1993;44:512-6 (in German).
135. Martner-Hewes PM, Hunt IF, Murphy NJ, Swendseid ME, Settlage RH. Vitamin B-6 nutriture and plasma diamine oxidase activity in pregnant Hispanic teenagers. Am J Clin Nutr 1986;44:907-13.
136. Raithel M, Konturek PC, Wildner S, et al. Evaluation der immunologischen Effekte von Bauchspeicheldrüsenenzymen bei gastrointestinal vermittelten Allergien (GMA) mittels doppel-blinder, placebokontrollierter Provokationstestung, ex vivo Mukosaosygenation und der in vitro Allergendegradation. (Evaluation of immunologic effects of pancreas enzymes in gastrointestinally mediated allergies (GMA) with the help of double-blind placebo-controlled provocation, ex vivo mucosa oxygenation, and in vitro allergen degradation. ) Allergo J 2005;14:41 (abstr) (in German).
137. Lorenz W, Ennis M, Doenicke A, Dick W. Perioperative uses of histamine antagonists. J Clin Anesth 1990;2:345-60.